Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sinew Pharma, Inc. (6634) Financial Statements

Sinew Pharma, Inc. Financial Overview

Sinew Pharma, Inc.'s market cap is currently NT$4.08B. The company's EPS TTM is NT$-1.66; its P/E ratio is -36.45; Sinew Pharma, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 47.00KNT$ 0.00NT$ 0.00NT$ 328.00KNT$ 6.23M
Gross ProfitNT$ -19.29MNT$ -30.31MNT$ -28.98MNT$ 290.00KNT$ 5.09M
Operating IncomeNT$ -140.13MNT$ -168.86MNT$ -186.25MNT$ -148.43MNT$ -94.42M
EBITDANT$ -120.80MNT$ -119.65MNT$ -157.27MNT$ -117.09MNT$ -68.78M
Net IncomeNT$ -123.75MNT$ -150.37MNT$ -170.92MNT$ -140.18MNT$ -91.58M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.05BNT$ 1.16BNT$ 1.28BNT$ 1.39BNT$ 1.48B
Total AssetsNT$ 1.13BNT$ 1.23BNT$ 1.36BNT$ 1.49BNT$ 1.58B
Total DebtNT$ 15.21MNT$ 2.82MNT$ 9.28MNT$ 7.54MNT$ 1.05M
Net DebtNT$ -10.06MNT$ -38.57MNT$ -157.53MNT$ -239.13MNT$ -550.12M
Total LiabilitiesNT$ 36.42MNT$ 28.88MNT$ 39.71MNT$ 28.66MNT$ 15.96M
Stockholders' EquityNT$ 1.09BNT$ 1.20BNT$ 1.32BNT$ 1.46BNT$ 1.57B
Cash Flow
Free Cash FlowNT$ -97.17MNT$ -107.41MNT$ -125.50MNT$ -99.64MNT$ -63.18M
Operating Cash FlowNT$ -95.30MNT$ -106.08MNT$ -118.05MNT$ -93.76MNT$ -57.32M
Investing Cash FlowNT$ 84.75MNT$ -16.69MNT$ 26.20MNT$ -221.15MNT$ -648.56M
Financing Cash FlowNT$ -5.58MNT$ -2.65MNT$ 11.98MNT$ 10.41MNT$ 1.21B

Currency in TWD

Sinew Pharma, Inc. Earnings and Revenue History

-200M-100M0100M-300000 %-200000 %-100000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Sinew Pharma, Inc. Liabilities to Assets

0600M1.2B1.8B0 %25 %50 %75 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Sinew Pharma, Inc. Cash Flow

-1B-500M0500M1B1.5B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Sinew Pharma, Inc. Forecast EPS vs Actual EPS

Earnings >